CORMEDIX INC. - COMMON STOCK
9.6500
01-5月-25 16:45:00
15 分の遅延
株式
+0.4600
+5.01%
本日の幅
9.0500 - 9.7800
ISIN
N/A
ソース
NASDAQ
-
CorMedix Inc. Announces Regulatory and Manufacturing Updates
02 3 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Promotions in Commercial and Tech Ops
17 1 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
06 12 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
CorMedix Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update
10 11 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
CorMedix Inc. Announces CMS Revision to NTAP Reimbursement of DefenCath
07 11 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
02 11 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Abstract Presentation at Upcoming American Society of Nephrology Conference
20 10 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference
07 9 2022 08:30:01 提供 Nasdaq GlobeNewswire
-
11 8 2022 07:30:01 提供 Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Regulatory and Manufacturing Updates
08 8 2022 16:05:02 提供 Nasdaq GlobeNewswire
-
CorMedix to Participate at the JMP Securities Life Sciences Conference
08 6 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
CorMedix Inc. Reports First Quarter 2022 Financial Results and Provides Business Update
12 5 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Leadership Updates and Operational Changes
12 5 2022 08:30:01 提供 Nasdaq GlobeNewswire
-
03 5 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
07 4 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference
04 4 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
29 3 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath
28 3 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
22 3 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
CorMedix Inc. Announces the Appointment of Chief Executive Officer
17 3 2022 08:30:00 提供 Nasdaq GlobeNewswire